United Therapeutics Corp

NASDAQ:UTHR   3:58:58 PM EDT
380.52
-10.93 (-2.79%)
3:59:59 PM EDT: $380.41 -0.11 (-0.03%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)17.21B
Current PE13.86
Forward PE 13.93
2yr Forward PE 13.06
See more stats
Estimates Current Quarter
Revenue$820.69 Million
Adjusted EPS$7.43
See more estimates
10-Day MA$344.93
50-Day MA$304.78
200-Day MA$324.59
See more pivots

United Therapeutics Corp Stock, NASDAQ:UTHR

1000 Spring Street, Silver Spring, Maryland 20910
United States of America
Phone: +1.301.608.9292
Number of Employees: 1305

Description

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.